Device Biocompatibility Assessment

Device biocompatibility assessment evaluates toxicological and immunological effects of materials contacting tissue or blood ensuring safe use. Cytotoxicity testing employs cell culture systems detecting toxic material extract effects. Sensitisation potential assessment determines allergenicity. Systemic toxicity evaluation follows parenteral material exposure. Haemocompatibility assessment measures blood component interactions.

International standards including ISO 10993 series establish biocompatibility testing requirements. Material-specific testing reflects anticipated use duration and contact intensity. Extractable substances identification and quantitation characterises toxicological hazards. Regulatory submissions include comprehensive biocompatibility documentation. Clinical safety monitoring detects unanticipated material-related adverse effects.